Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo [4,5-f]quinoline in the human breast

Pharmacogenetics

Volumn 8, Issue 6, 1998, Pages 519-528

  Williams, J Andrew ^a   Stone, Elaine M ^a   Millar, Barbara C ^a   Gusterson, Barry A ^a   Grover, Philip L ^a   Phillips, David H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cytochrome P450; DNA adducts; Myeloperoxidase; Polymerase chain reaction; Reverse transcription

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; ALPHA NAPHTHOFLAVONE; BENZ[A]ANTHRACENE; CYTOCHROME P450 INHIBITOR; HETEROCYCLIC AMINE; ICOSATETRAYNOIC ACID; INDOMETACIN; LIPOXYGENASE; PROADIFEN; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM AZIDE;

ADULT; ARTICLE; BREAST; BREAST CANCER; BREAST EPITHELIUM; CELL TYPE; CONTROLLED STUDY; DIET; DNA ADDUCT; DNA BINDING; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN TISSUE; NEUTROPHIL; PRIORITY JOURNAL;

ANIMALIA; RODENTIA; TRIXIS;

EID: 0032422898     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199812000-00009     Document Type: Article

References (48)

1. Back DJ, Stevenson P, Tjia JF. Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro. Br J Clin Pharmacol 1989; 28:166-170.
2. Baldwin SJ, Bloomer JC, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 1995; 25:261-270.
3. Biggs PJ, Warren W, Venitt S, Stratton MR. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 1993; 8:275-283.
4. Boobis AR, Lynch AM, Murray S, de la Torre R, Solans A, Farre M, et al. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res 1994; 54:89-94.
5. Boyum A. Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 21:1-6.
6. Carmichael PL, Stone EM, Grover PL, Gusterson BA, Phillips DH. Metabolic activation and DNA binding of food mutagens and other environmental carcinogens in human mammary epithelial cells. Carcinogenesis 1996; 17:1769-1772.
7. Corbett MD, Corbett BR, Hannothiaux MH, Quintana SJ. Metabolic activation and nucleic acid binding of acetaminophen and related arylamine substrates by the respiratory burst of human granulocytes. Chem Res Toxicol 1989; 2:260-266.
8. Crofts FG, Strickland PT, Hayes CL, Sutter TR. Metabolism of 2-amino-1-methyl-6-phenyliminodazo (4,5b)pyridine (PhIP) by human cytochrome CYP1B1. Carcinogenesis 1997; 18:1793-1798.
9. Donnelly PJ, Stewart RK, Ali SL, Conlan AA, Reid KR, Petsikas D, Massey TE. Biotransformation of aflatoxin B1 in human lung. Carcinogenesis 1996; 17:2487-2494.
10. Easty GC, Easty DM, Monaghan P, Ormerod MG, Neville AM. Preparation and identification of human breast epithelial cells in culture. Int J Cancer 1980; 26:577-584.
11. El-Bayoumy K. Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol 1992; 5:585-590.
12. Endo H, Schut HA, Snyderwine EG. Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system. Cancer Res 1994; 54:3745-3751.
13. Foote CS, Coyne TE, Lehrer RI. Assessment of chlorination by human neutrophils. Nature 1983; 301:715-716.
14. 32-postlabelling analysis of non-radioactive aromatic carcinogen DNA adducts. Cancer Res 1985; 45:5656-5662.
15. Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S, Anttila S, et al. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 1997; 18:391-397.
16. Hall M, Ni She M, Wild D, Fasshauer I, Hewer A, Phillips DH. Tissue distribution of DNA adducts in CDF1 mice fed 2-amino-3-methylimidazo[4,5-f] quinoline and 2-amino-3,4-dimethylimidazo[4,5-f] quinoline (MeIQ). Carcinogenesis 1990; 11:1005-1011.
17. Kikuta Y, Kusunose E, Endo K, Yamamoto S, Sogawa K, Fujii-Kuriyama Y, Kusunose M. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. DNA cloning and expression of leukotriene B4 omega-hydroxylase. J Biol Chem 1993; 268:9376-9380.
18. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997; 57:5001-5003.
19. Martin FL, Carmichael PL, Crofton-Sleigh C, Venitt S, Phillips DH, Grover PL. Genotoxicity of human mammary lipid. Cancer Res 1996; 56:5342-5346.
20. Martin FL, Venitt S, Carmichael PL, Crofton-Sleigh C, Stone EM, Cole KJ, et al. DNA damage in breast epithelial cells: detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts. Carcinogenesis 1997; 18:2299-2305.
21. McKay JA, Melvin WT, Ah-See AK, Ewen SWB, Greenlee WF, Marcus CB, et al. Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Letters 1995; 374:270-272.
22. Mercurio MG, Shiff SJ, Galbraith RA, Sassa S. Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem Biophys Res Commun 1995; 210:350-355.
23. Moorthy B, Sriram P, Randerath K. Chemical structure- and time-dependent effects of polycyclic aromatic hydrocarbon-type inducers on rat liver cytochrome P450. DNA adducts, and 1-compounds. Fundam Appl Toxicol 1994; 22:549-560.
24. Nagao M, Ushijima T, Wakabayashi K, Ochiai M, Kushida H, Sugimura T, et al. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines. Cancer 1994; 74:1063-1069.
25. Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, et al. Lactation and a reduced risk of premenopausal breast cancer. N Engl Med 1994; 330:81-87.
26. O'Hare MJ, Ormerod MJ, Monaghan P, Lane EB, Gusterson BA. Characterisation in vitro of luminal and myoepithelial cells isolated from human mammary gland by cell sorting. Differentiation 1991; 46:209-221.
27. Panousis C, Kettle AJ, Phillips DR. Neutrophil-mediated activation of mitoxantrone to metabolites which form adducts with DNA. Cancer Letters 1997; 113:173-178.
28. Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 1996; 74:1-5.
29. Persson-Waller K, Colditz IG, Seow HF. Accumulation of leucocoytes and cytokines in the lactating ovine udder during mastitis due to Staphylococcus aureus and Escherichia coli. Res Vet Sci 1947; 62:63-66.
30. Pfau W, O'Hare MJ, Grover PL, Phillips DH. Metabolic activation of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) to DNA binding species in human mammary epithelial cells Carcinogenesis 1992; 13:907-909.
31. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. Carcinogenesis 1994; 15:877-882.
32. Pfau W, Stone EM, Brockstedt U, Carmichael PL, Marquardt H, Phillips DH. DNA adducts in human breast tissue: influence of NAT2 genotype. Manuscript in preparation.
33. Pouliot M, McDonald PP, Khamzina L, Borgeat P, McColl SR, Granulocyte-macrophage colony-stimulating factor enhances 5- lipoxygenase levels in human polymorphonuclear leukocytes. J Immunol 1994; 152:851-858.
34. Prutz WA. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch Biochem Biophys 1996; 332:110-120.
35. Richards KM, Marnett LJ. Leukocyte 12-lipoxygenase: expression, purification, and investigation of the role of methionine residues in turnover-dependent inactivation and 5.8.11.14-eicosatetraynoic acid inhibition. Biochemistry 1997; 36:6692-6699.
36. Sadrieh N, Davis CD, Snyderwine EG. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res 1996; 56:2683-2687.
37. Shimada T, El-Bayoumy K, Upadhyaya P, Sutter T, Guengerich FP, Yamazaki H. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Cancer Res 1997; 57:4757-4764.
38. Smith TJ, Liao AM, Liu Y, Jones AB, Anderson LM, Yang CS. Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. Carcinogenesis 1997; 18:1577-1584.
39. Srebernik N, Morgan JP, Baker AJ, Gooderham NJ. Human neutrophils can activate the food-derived carcinogen MeIQx. Biochem Soc Trans 1990; 18:610-611.
40. Stone EM, Williams JA, Grover PL, Gusterson BA, Phillips DH. Interindividual variation in the metabolism of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells. Carcinogenesis 1998; 19:873-879.
41. Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H, Nishimori I. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki. Radiation Res 1987; 112:243-272.
42. Trush MA, Seed JL, Kensler TW. Oxidation-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer. Proc Natl Acad Sci USA 1985; 82:5194-5198.
43. Tsuruta Y, Josephy PD, Rahimtula AD. Peroxidase-catalyxed benzidine binding to DNA and other macromolecules. Chem Biol Interact 1985a; 54:143-158.
44. Tsuruta Y, Subrahmanyam VV, Marshall W. Peroxidase-mediated irreversible binding of arylamine carcinogens to DNA in intact polymorphonuclear leukocytes activated by a tumor promoter. Chem Biol Interact 1985b; 53:25-35.
45. Turesky RJ, Box RM, Markovic J, Gremaud E, Snyderwine EG. Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline the rat and nonhuman primates. Mutat Res 1997; 376:235-241.
46. van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BG. Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Methods 1996; 191:187-196.
47. Willett WC. Diet, nutrition, and avoidable cancer. Environ Health Perspect 1995; 103 (suppl 8):165-170.
48. Wolz E, Wild D, Degen GH. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ). Arch Toxicol 1995; 69:171-179.